landmark NIH hypertension study will change how patients with high blood pressure are treated

January 2003

New results from the landmark NIH hypertension study will change how patients with high blood pressure are treated.

Currently, most hypertension patients start on an ACE inhibitor, beta-blocker, or calcium channel blocker.

A thiazide diuretic is often added when extra blood pressure control is needed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote